Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes

References

• WeiKRYuXZhengRSIncidence and mortality of liver cancer in China, 2010Chin J Cancer2014838839425104174
   PubMedGoogle Scholar
• SiegelABOlsenSKMagunABrownRSSorafenib: where do we go from here?Hepatology201052136036920578152
   PubMed Web of Science ®Google Scholar
• LiHPiaoLYuBDelivery of calf thymus DNA to tumor by folate receptor targeted cationic liposomesBiomaterials201132276614662021665267
   PubMed Web of Science ®Google Scholar
• AravalliRNCressmanENSteerCJCellular and molecular mechanisms of hepatocellular carcinoma: an updateArch Toxicol201387222724723007558
   PubMed Web of Science ®Google Scholar
• AravalliRNSteerCJCressmanENMolecular mechanisms of hepatocellular carcinomaHepatology20084862047206319003900
   PubMed Web of Science ®Google Scholar
• HuangSHeXThe role of microRNAs in liver cancer progressionBr J Cancer2011104223524021102580
   PubMed Web of Science ®Google Scholar
• LandenCNJrChavez-ReyesABucanaCTherapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA deliveryCancer Res200565156910691816061675
   PubMed Web of Science ®Google Scholar
• ShenGRongXZhaoJMicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinomaCarcinogenesis201435122748275525280563
   PubMed Web of Science ®Google Scholar
• ZhaoQLiTQiJLiuJQinCThe miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progressionPLoS One2014910e10978225299640
   PubMed Web of Science ®Google Scholar
• GaoKHuangLNonviral methods for siRNA deliveryMol Pharm20096365165819115957
   PubMedGoogle Scholar
• ChoungSKimYJKimSParkHOChoiYCChemical modification of siRNAs to improve serum stability without loss of efficacyBiochem Biophys Res Commun2006342391992716598842
   PubMed Web of Science ®Google Scholar
• YildizILeeKLChenKShuklaSSteinmetzNFInfusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and deliveryJ Control Release2013172256857823665254
   PubMed Web of Science ®Google Scholar
• RothdienerMMüllerDCastroPGTargeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systemsJ Control Release2010144225125820184933
   PubMed Web of Science ®Google Scholar
• SokolovaVEppleMInorganic nanoparticles as carriers of nucleic acids into cellsAngew Chem Int Ed Engl20084781382139518098258
   PubMed Web of Science ®Google Scholar
• TaratulaOGarbuzenkoOBKirkpatrickPSurface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA deliveryJ Control Release2009140328429319567257
   PubMed Web of Science ®Google Scholar
• ZhuCJungSLuoSCo-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PD-MAEMA triblock copolymersBiomaterials20103182408241619963269
   PubMed Web of Science ®Google Scholar
• PatelAPatelMYangXMitraAKRecent advances in protein and peptide drug delivery: a special emphasis on polymeric nanoparticlesProtein Pept Lett201421111102112025106908
   PubMed Web of Science ®Google Scholar
• GandhiNSTekadeRKChouguleMBNanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advancesJ Control Release2014194c23825625204288
   PubMed Web of Science ®Google Scholar
• ChenYZhuXZhangXLiuBHuangLNanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapyMol Ther20101891650165620606648
   PubMed Web of Science ®Google Scholar
• ZhangMZhouXWangBLactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinomaJ Control Release2013168325126123567045
   PubMed Web of Science ®Google Scholar
• HatakeyamaHMurataMSatoYThe systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in miceJ Control Release2013173435024511611
   PubMed Web of Science ®Google Scholar
• FornariFGramantieriLFerracinMMiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinomaOncogene200827435651566118521080
   PubMed Web of Science ®Google Scholar
• GarofaloMDi LevaGRomanoGmiR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulationCancer Cell200916649850919962668
   PubMed Web of Science ®Google Scholar
• MedinaRZaidiSKLiuCGMicroRNAs 221 and 222 bypass quiescence and compromise cell survivalCancer Res20086882773278018413744
   PubMed Web of Science ®Google Scholar
• IppolitiRLendaroED’AgostinoIA chimeric saporin-transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicityFASEB J1995912122012257672515
   PubMed Web of Science ®Google Scholar
• LiXDingLXuYWangYPingQTargeted delivery of doxorubicin using stealth liposomes modified with transferrinInt J Pharm20093731–211612319429296
   PubMed Web of Science ®Google Scholar
• SakuraiKSohdaTUedaSImmunohistochemical demonstration of transferrin receptor 1 and 2 in human hepatocellular carcinoma tissueHepatogastroenterology20146113042643024901155
   PubMedGoogle Scholar
• ParkJKKogureTNuovoGJmiR-221 silencing blocks hepatocellular carcinoma and promotes survivalCancer Res201171247608761622009537
   PubMed Web of Science ®Google Scholar
• FireAXuSMontgomeryMKKostasSADriverSEMelloCCPotent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature199839166698068119486653
   PubMed Web of Science ®Google Scholar
• ZhangGWangQXuRTherapeutics based on microRNA: a new approach for liver cancerCurr Genomics201011531132521286309
   PubMed Web of Science ®Google Scholar
• LiJWangYYuWChenJLuoJExpression of serum miR-221 in human hepatocellular carcinoma and its prognostic significanceBiochem Biophys Res Commun20114061707321295551
   PubMed Web of Science ®Google Scholar
• YuanQLoyaKRaniBMicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regenerationHepatology201357129931022821679
   PubMed Web of Science ®Google Scholar
• HuangYYangTZhangWA novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivoInt J Nanomedicine201494581459525302024
   PubMed Web of Science ®Google Scholar
• XiangGWuJLuYLiuZLeeRJSynthesis and evaluation of a novel ligand for folate-mediated targeting liposomesInt J Pharm20083561–2293618258394
   PubMed Web of Science ®Google Scholar
• YePZhangWYangTFolate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targetingInt J Nanomedicine201492167217824855354
   PubMed Web of Science ®Google Scholar
• LiuYMounkesLCLiggittHDFactors influencing the efficiency of cationic liposome-mediated intravenous gene deliveryNat Biotechnol19971521671739035144
   PubMed Web of Science ®Google Scholar
• RossiJJMedicine: a cholesterol connection in RNAiNature2004432701415515615538347
   PubMed Web of Science ®Google Scholar
• GasparMMRadomskaAGobboOLBakowskyURadomskiMWEhrhardtCTargeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude ratsJ Aerosol Med Pulm Drug Deliv201225631031822857016
   PubMed Web of Science ®Google Scholar
• DeryckeASKamuhabwaAGijsensATransferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cellsJ Natl Cancer Inst200496211620163015523091
   PubMedGoogle Scholar
• HaoZFCuiYXLiMHLiposomes modified with P-aminophenyl-alpha-D-mannopyranoside: a carrier for targeting cerebral functional regions in miceEur J Pharm Biopharm201384350551623376242
   PubMed Web of Science ®Google Scholar
• ChiuRYTsujiTWangSJWangJLiuCTKameiDTImproving the systemic drug delivery efficacy of nanoparticles using a transferrin variant for targetingJ Control Release2014180334124524898
   PubMed Web of Science ®Google Scholar
• EltayebSESuZShiYLiSXiaoYPingQPreparation and optimization of transferrin-modified-artemether lipid nanospheres based on the orthogonal design of emulsion formulation and physically electrostatic adsorptionInt J Pharm20134521–232133223694805
   PubMedGoogle Scholar
• WallaceDFSummervilleLSubramaniamVNTargeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overloadGastroenterology2007132130131017241880
   PubMed Web of Science ®Google Scholar
• VisoneRRussoLPallantePMicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycleEndocr Relat Cancer200714379179817914108
   PubMed Web of Science ®Google Scholar
• GalardiSMercatelliNGiordaEmiR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1J Biol Chem200728232237162372417569667
   PubMed Web of Science ®Google Scholar